SCHEMBL29894580

SCHEMBL29894580

Oc1ccc(Br)c(O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69381 1.00
Resorcinol SCHEMBL8977987 0.90 CYP3A4 (0.57)
SCHEMBL6379998 0.79 MAOB (0.38)
SCHEMBL1047274 0.79
SCHEMBL29617570 0.79
SCHEMBL5431572 0.78 TSHR (0.54)
SCHEMBL2471986 0.77 APP (0.55)
SCHEMBL9440083 0.77 ESR1 (0.46)
SCHEMBL582238 0.77
SCHEMBL29457568 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118638106-A Novel method for synthesizing hexamethylation sophoraflavanone J 西南交通大学 2024-09-13 CN claimed
CN-116284026-B Water-soluble cation molecular cage and synthetic method and application thereof 天津师范大学 2024-05-14 CN claimed
CN-116284026-A Water-soluble cation molecular cage and synthetic method and application thereof 天津师范大学 2023-06-23 CN claimed
EP-3894471-B1 TYRE AND ELASTOMERIC COMPOUND FOR TYRE, COMPRISING CROSS-LINKED PHENOLIC RESINS PIRELLI (IT) 2023-05-17 EP claimed
CN-113336735-B Urolithin compound, preparation method, pharmaceutical composition and application 常州大学 2022-09-30 CN claimed
CN-122037030-A Ultraviolet-resistant elastic stretchable EVA resin and application thereof 江苏海洋大学 2026-05-15 CN disclosed
EP-4698520-A1 RAF-MEK PROTEIN COMPLEX MODULATORS AND METHODS OF USE THEREOF Gandeeva Therapeutics, Inc. (US) 2026-02-25 EP disclosed
WO-2025096856-A1 COVALENT CEREBLON LIGANDS C4 THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
CN-119306737-A Benzo heterocyclic compound, pharmaceutically acceptable salt or stereoisomer thereof, and preparation method and application thereof 江苏集萃分子工程研究院有限公司 2025-01-14 CN disclosed
CN-119212699-A NLRP3 inhibitors PTC医疗公司 2024-12-27 CN disclosed
EP-4479045-A2 INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2024220708-A1 RAF-MEK PROTEIN COMPLEX MODULATORS AND METHODS OF USE THEREOF GANDEEVA THERAPEUTICS, INC. (US) 2024-10-24 WO disclosed
CN-115181082-B Synthetic method of natural molecule Moracin M 江苏集萃分子工程研究院有限公司 2023-11-03 CN disclosed
CN-116730992-A I-type hemicyanine photosensitizer, I-type targeting photosensitizer, and preparation methods and application thereof 苏州大学 2023-09-12 CN disclosed
WO-2023159148-A2 INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed
CN-116284026-A Water-soluble cation molecular cage and synthetic method and application thereof 天津师范大学 2023-06-23 CN disclosed
WO-2022248947-A1 SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-12-01 WO disclosed
CN-113336735-B Urolithin compound, preparation method, pharmaceutical composition and application 常州大学 2022-09-30 CN disclosed
WO-2022195364-A1 POLYMERIZABLE 4,4'-SPIROBI[CHROMANE]-2,2'-DIONES AND CURABLE COMPOSITIONS INCLUDING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-09-22 WO disclosed
CN-110114343-B Pyrazolopyrimidine compounds and methods of use thereof 豪夫迈·罗氏有限公司 2022-09-06 CN disclosed